TMC Life Sciences (KLSE:TMCLIFE) said its profit attributable to owners plunged to 2.9 million ringgit in the fiscal first quarter ended Sept. 30 from 15.1 million ringgit a year earlier.
Earnings per share fell to 0.0017 ringgit, from 0.0087 ringgit a year ago, according to a Monday bourse disclosure.
Revenue shrank to 82 million ringgit from 92.4 million ringgit a year ago, the healthcare services provider said.
The board did not recommend a dividend for the period.
The company is a unit of Thomson Medical Group (SGX:A50).
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。